Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]

View source ↗

Summary

Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• Ad-ISF35

Snippet

Sponsor: Januario Castro, M.D. | Conditions: Non-Hodgkin's Lymphoma, Follicular Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2015-11-20